Based on our results in this study using a cell culture model, we hypothesize that addition of extra doses of a P-gp inhibitor (compound 29 was used here) after the initial chemotherapy treatments would likely increase the intracellular retention of chemotherapeutics in the patients’ cancer cells. The gene discussed is PGP; the disease is cancer.